. 1. Ii,

?. 1. Ii,

. 2. Ii,

. Ii and . .. Au-tabagisme, 3.2Impact sur la qualité de vie et la mortalité toutes causes confondues
URL : https://hal.archives-ouvertes.fr/hal-00575774

. Ii, . En, . Dans-la, and . .. Generale,

. .. Iiitrouble-bipolaire,

I. Michot, Julien Morel d'Arleux, Observatoire Français des Drogues et des Toxicomanies, Coordination : Julie-Emilie Adès Maquette : Frédérique Million Documentation, vol.8, 2019.

A. Commar, V. K. Prasad, E. Tursan-d'espaignet, L. Wolfenden, and W. , WHO global report on trends in prevalence of tobacco smoking, 2000.

K. Lasser, J. W. Boyd, S. Woolhandler, D. U. Himmelstein, D. Mccormick et al., Smoking and Mental Illness: A Population-Based Prevalence Study, JAMA, vol.284, issue.20, p.2606, 2000.

F. Dickerson, J. Schroeder, E. Katsafanas, S. Khushalani, A. E. Origoni et al., Cigarette Smoking by Patients With Serious Mental Illness, 1999-2016: An Increasing Disparity, Psychiatr Serv. févr, vol.69, issue.2, pp.147-53, 2018.

F. Dickerson, A. Origoni, J. Schroeder, M. Adamos, E. Katsafanas et al., Natural cause mortality in persons with serious mental illness, Acta Psychiatr Scand. mai, vol.137, issue.5, pp.371-380, 2018.

J. Goodman, Tobacco in History: The Cultures of Dependence. illustrated, reprint, revised. Routledge, vol.280, 1994.

C. G. Husten, How should we define light or intermittent smoking? Does it matter?, Nicotine Tob Res. 5 mars, vol.11, issue.2, pp.111-132, 2009.

, United States Surgeon General. The Health Consequences of Smoking --50 Years of progress: A, Report of the Surgeon General

, American Psychological Association, 2014.

, Diagnostical and Statistical Manual of Mental Disorders, 2013.


M. J. Thun, L. F. Apicella, and S. J. Henley, Smoking vs Other Risk Factors as the Cause of Smoking-Attributable Deaths: Confounding in the Courtroom, JAMA. 9 août, vol.284, issue.6, p.706, 2000.

Y. Lee, C. Cohet, Y. Yang, L. Stayner, M. Hashibe et al., Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer, Int J Epidemiol. déc, vol.38, issue.6, pp.1497-511, 2009.

E. Botteri, S. Iodice, V. Bagnardi, S. Raimondi, A. B. Lowenfels et al., Smoking and Colorectal Cancer: A Meta-analysis, JAMA. 17 déc, vol.300, issue.23, p.2765, 2008.

M. Underner, G. Peiffer, J. Perriot, G. Harika-germaneau, and N. Jaafari, La diminution de la consommation de tabac est-elle associée à une réduction du risque de morbi-mortalité cardiovasculaire et pulmonaire ?, Rev Pneumol Clin. juin, vol.74, issue.3, pp.188-95, 2018.

, Rapport de l'OMS sur l'épidémie mondiale de tabagisme. OMS, 2008.

W. Abascal and A. Lorenzo, Impacto de la política de control de tabaco en población adolescente en Uruguay, Salud Pública México. 31 mars, vol.59, p.40, 2017.

R. Française, Programme Nationnal de Réduction du TAbagisme, 2014.

, Haute Autorité de santé, vol.60, 2014.

S. Lf, Nicotine replacement therapy for smoking cessation, vol.267, 2012.

K. Cahill, N. Lindson-hawley, K. H. Thomas, T. R. Fanshawe, and T. Lancaster, Nicotine receptor partial agonists for smoking cessation. Cochrane Tobacco Addiction Group, éditeur. Cochrane Database Syst Rev, 2016.

D. Sur,

R. M. Anthenelli, N. L. Benowitz, R. West, L. St-aubin, T. Mcrae et al., Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial, The Lancet. juin, vol.387, pp.2507-2527, 2016.

H. Jr and S. Lf, Antidepressants for smoking cessation, p.145, 2014.

L. F. Stead, D. Buitrago, N. Preciado, G. Sanchez, J. Hartmann-boyce et al., Physician advice for smoking cessation. Cochrane Tobacco Addiction Group, éditeur. Cochrane Database Syst Rev, pp.31-2013

D. Sur,

J. Abdul-kader, G. Airagnes, D. 'almeida, S. Limosin, F. et al., Les outils du sevrage tabagique en 2018, Rev Pneumol Clin. juin, vol.74, issue.3, pp.160-169, 2018.

R. El-dib, E. A. Suzumura, E. A. Akl, H. Gomaa, A. Agarwal et al., Electronic nicotine delivery systems and/or electronic non-nicotine delivery systems for tobacco smoking cessation or reduction: a systematic review and meta-analysis, BMJ Open. févr, vol.7, issue.2, p.12680, 2017.

M. L. Phillips and D. J. Kupfer, Bipolar disorder diagnosis: challenges and future directions, The Lancet. mai, vol.381, issue.9878, pp.1663-71, 2013.

K. R. Merikangas, J. R. He, J. Kessler, R. C. Lee, S. Sampson et al., Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative, Arch Gen Psychiatry. 7 mars, vol.68, issue.3, p.241, 2011.

A. Nivoli, I. Pacchiarotti, A. R. Rosa, D. Popovic, A. Murru et al., Gender differences in a cohort study of 604 bipolar patients: The role of predominant polarity, J Affect Disord, vol.133, issue.3, pp.443-452, 2011.

J. Hättenschwiler, P. Höck, R. Luther, J. Modestin, and E. Seifritz, Troubles bipolaires: diagnostic. Forum Med Suisse, p.751, 2009.

F. Rouillon, Épidémiologie des troubles psychiatriques, Ann Méd-Psychol Rev Psychiatr. févr, vol.166, issue.1, pp.63-70, 2008.

, World Health Organization, WHO. The ICD-10 Classification of Mental and Behavioural Disorders: diagnostic criteria for research, 1993.

N. Craddock and I. Jones, Review article Genetics of bipolar disorder, Hyman SE, éditeur, pp.29-38

I. Grande, M. Berk, B. Birmaher, and E. Vieta, Bipolar disorder. The Lancet, avr, vol.387, pp.1561-72, 2016.

M. Berk, Neuroprogression: pathways to progressive brain changes in bipolar disorder, Int J Neuropsychopharmacol. mai, vol.12, issue.04, p.441, 2009.

R. H. Perlis, M. J. Ostacher, J. K. Patel, L. B. Marangell, H. Zhang et al., Predictors of Recurrence in Bipolar Disorder: Primary Outcomes From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD), Am J Psychiatry, vol.8, 2006.

E. C. Harris and B. Barraclough, Suicide as an outcome for mental disorders: A meta-analysis, Br J Psychiatry. mars, vol.170, issue.3, pp.205-233, 1997.

L. L. Judd, H. S. Akiskal, P. J. Schettler, J. Endicott, J. Maser et al., The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder, Arch Gen Psychiatry. 1 juin, vol.59, issue.6, p.530, 2002.

L. L. Judd, H. S. Akiskal, P. J. Schettler, W. Coryell, J. Endicott et al., A Prospective Investigation of the Natural History of the Long-term Weekly Symptomatic Status of Bipolar II Disorder, Arch Gen Psychiatry. 1 mars, vol.60, issue.3, p.261, 2003.

C. Bourne, Ö. Aydemir, V. Balanzá-martínez, E. Bora, S. Brissos et al., Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis, Acta Psychiatr Scand. sept, vol.128, issue.3, pp.149-62, 2013.

A. R. Rosa, I. González-ortega, A. González-pinto, E. Echeburúa, M. Comes et al., One-year psychosocial functioning in patients in the early vs. late stage of bipolar disorder: Functioning in patients with first-vs. multiple-episode bipolar disorder, Acta Psychiatr Scand. avr, vol.125, issue.4, pp.335-376, 2012.

D. M. Novick, H. A. Swartz, and E. Frank, Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence, Bipolar Disord. févr, vol.12, issue.1, pp.1-9, 2010.

S. L. Mcelroy, L. L. Altshuler, T. Suppes, P. E. Keck, M. A. Frye et al., Axis I Psychiatric Comorbidity and Its Relationship to Historical Illness Variables in 288 Patients With Bipolar Disorder, Am J Psychiatry. mars, vol.158, issue.3, pp.420-426, 2001.

J. Kahn, Comorbidités et troubles bipolaires, L'Encéphale. août, vol.32, issue.4, pp.511-515, 2006.

G. E. Hunt, G. S. Malhi, M. Cleary, H. Lai, and T. Sitharthan, Prevalence of comorbid bipolar and substance use disorders in clinical settings, 1990-2015: Systematic review and meta-analysis, J Affect Disord. déc, vol.206, pp.331-380, 2016.

D. Vancampfort, C. U. Correll, B. Galling, M. Probst, D. Hert et al., Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis, World Psychiatry. juin, vol.15, issue.2, pp.166-74, 2016.

S. V. Lala and M. Sajatovic, Medical and Psychiatric Comorbidities Among Elderly Individuals With Bipolar Disorder: A Literature Review, J Geriatr Psychiatry Neurol. mars, vol.25, issue.1, pp.20-25, 2012.

S. Dittmann, N. C. Biedermann, H. Grunze, B. Hummel, L. O. Schärer et al., The Stanley Foundation Bipolar Network: Results of the Naturalistic Follow-Up Study after 2.5 Years of Follow-Up in the German Centres, Neuropsychobiology, vol.46, issue.1, pp.2-9, 2002.

S. Pini, V. De-queiroz, D. Pagnin, L. Pezawas, J. Angst et al., Prevalence and burden of bipolar disorders in European countries, Eur Neuropsychopharmacol. août, vol.15, issue.4, pp.425-459, 2005.

D. Gupta, R. Guest, and J. F. , Annual cost of bipolar disorder to UK society, Br J Psychiatry. mars, vol.180, issue.3, pp.227-260, 2002.

E. Toffol, T. Hätönen, A. Tanskanen, J. Lönnqvist, K. Wahlbeck et al., Lithium is associated with decrease in all-cause and suicide mortality in high-risk bipolar patients: A nationwide registry-based prospective cohort study, J Affect Disord. sept, vol.183, pp.159-65, 2015.

J. G. Jackson, F. J. Diaz, L. Lopez, and J. De-leon, A combined analysis of worldwide studies demonstrates an association between bipolar disorder and tobacco smoking behaviors in adults. Bipolar Disord, sept, vol.17, issue.6, pp.575-97, 2015.

A. Kreinin, D. Novitski, D. Rabinowitz, A. Weizman, and A. Grinshpoon, Association between tobacco smoking and bipolar affective disorder: clinical, epidemiological, cross-sectional, retrospective study in outpatients, Compr Psychiatry. avr, vol.53, issue.3, pp.269-74, 2012.

J. A. Waxmonsky, M. R. Thomas, D. J. Miklowitz, M. H. Allen, S. R. Wisniewski et al., Prevalence and correlates of tobacco use in bipolar disorder: data from the first 2000 participants in the Systematic Treatment Enhancement Program, Gen Hosp Psychiatry. sept, vol.27, issue.5, pp.321-329, 2005.

F. J. Diaz, D. James, S. Botts, L. Maw, M. T. Susce et al., Tobacco smoking behaviors in bipolar disorder: a comparison of the general population, schizophrenia, and major depression, Bipolar Disord. mars, vol.11, issue.2, pp.154-65, 2009.

A. K. Mcclave, L. R. Mcknight-eily, S. P. Davis, and S. R. Dube, Smoking Characteristics of Adults With Selected Lifetime Mental Illnesses: Results From the 2007 National Health Interview Survey, Am J Public Health. déc, vol.100, issue.12, pp.2464-72, 2010.

T. E. Wilens, J. Biederman, J. J. Adamson, A. Henin, S. Sgambati et al., Further evidence of an association between adolescent bipolar disorder with smoking and substance use disorders: A controlled study, Drug Alcohol Depend. juin, vol.95, issue.3, pp.188-98, 2008.

T. Yeh, S. Wang, Y. Chang, and C. Yeh, Predictors of Nicotine Dependence in Adolescents: Symptoms of Bipolar Disorder and Attention-Deficit/Hyperactivity Disorder, J Child Adolesc Psychopharmacol. mai, vol.27, issue.4, pp.366-73, 2017.

G. C. Medeiros, B. Lafer, F. Kapczinski, Â. Miranda-scippa, and K. M. Almeida, Bipolar disorder and tobacco smoking: Categorical and dimensional clinical correlates in subjects from the Brazilian bipolar research network, Compr Psychiatry. avr, vol.82, pp.14-21, 2018.

I. Soreca, A. Fagiolini, E. Frank, P. R. Houck, W. K. Thompson et al., Relationship of general medical burden, duration of illness and age in patients with bipolar I disorder, J Psychiatr Res. sept, vol.42, issue.11, pp.956-61, 2008.

P. A. Vanable, M. P. Carey, K. B. Carey, and S. A. Maisto, Smoking Among Psychiatric Outpatients: Relationship to Substance Use, Diagnosis, and Illness Severity, Psychol Addict Behav, vol.17, issue.4, pp.259-65, 2003.

. Ostacher, The Relationship Between Smoking and Suicidal Behavior, Comorbidity, and Course of Illness in Bipolar Disorder, J Clin Psychiatry, vol.67, pp.1907-1918, 2006.

D. Li, X. Yang, Z. Ge, Y. Hao, Q. Wang et al., Cigarette smoking and risk of completed suicide: A meta-analysis of prospective cohort studies, J Psychiatr Res, vol.46, issue.10, pp.1257-66, 2012.

B. I. Goldstein, B. Birmaher, D. A. Axelson, T. R. Goldstein, C. Esposito-smythers et al., Significance of Cigarette Smoking Among Youths with Bipolar Disorder, Am J Addict. janv, vol.17, issue.5, pp.364-71, 2008.

D. Ducasse, I. Jaussent, S. Guillaume, J. M. Azorin, F. Bellivier et al., Increased risk of suicide attempt in bipolar patients with severe tobacco dependence, J Affect Disord. sept, vol.183, pp.113-121, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01989463

M. Berk, F. Ng, W. V. Wang, M. Tohen, D. I. Lubman et al., Going up in smoke: Tobacco smoking is associated with worse treatment outcomes in mania, J Affect Disord. sept, vol.110, issue.1-2, pp.126-160, 2008.

A. Corvin, E. O'mahony, O. 'regan, M. Comerford, C. O'connell et al., Cigarette smoking and psychotic symptoms in bipolar affective disorder, Br J Psychiatry. juill, vol.179, issue.1, pp.35-43, 2001.

F. Cassidy, J. P. Mcevoy, Y. K. Yang, and W. H. Wilson, Smoking and psychosis in patients with bipolar I disorder, Compr Psychiatry. janv, vol.43, issue.1, pp.63-67, 2002.

S. M. Hartz, C. N. Pato, H. Medeiros, P. Cavazos-rehg, J. L. Sobell et al., Comorbidity of Severe Psychotic Disorders With Measures of Substance Use, JAMA Psychiatry. 1 mars, vol.71, issue.3, p.248, 2014.

E. Estrada, S. M. Hartz, J. Tran, D. M. Hilty, P. Sklar et al., Nicotine dependence and psychosis in Bipolar disorder and Schizoaffective disorder, Bipolar type, Am J Med Genet B Neuropsychiatr Genet. juin, vol.171, issue.4, pp.521-525, 2016.

S. M. Weinstein, R. Mermelstein, S. Shiffman, and B. Flay, Mood variability and cigarette smoking escalation among adolescents, Psychol Addict Behav, vol.22, issue.4, pp.504-517, 2008.

W. G. Ter-meulen, J. Van-zaane, S. Draisma, A. Beekman, and R. W. Kupka, Does the number of previous mood episodes moderate the relationship between alcohol use, smoking and mood in bipolar outpatients? BMC Psychiatry, Disponible sur, vol.17, 2017.

I. Berlin, M. Anthenelli, and R. , Monoamine oxidases and tobacco smoking, Int J Neuropsychopharmacol, 2001.

Y. S. Mineur and M. R. Picciotto, Biological Basis for the Co-morbidity Between Smoking and Mood Disorders, J Dual Diagn. 22 mai, vol.5, issue.2, pp.122-152, 2009.

J. A. Gandelman, P. Newhouse, and W. D. Taylor, Nicotine and networks: Potential for enhancement of mood and cognition in late-life depression, Neurosci Biobehav Rev. janv, vol.84, pp.289-98, 2018.

M. M. Kurtz and R. T. Gerraty, A meta-analytic investigation of neurocognitive deficits in bipolar illness: Profile and effects of clinical state, Neuropsychology, vol.23, issue.5, pp.551-62, 2009.

S. J. Heishman, B. A. Kleykamp, and E. G. Singleton, Meta-analysis of the acute effects of nicotine and smoking on human performance, Psychopharmacology (Berl). juill, vol.210, issue.4, pp.453-69, 2010.

D. Caldirola, S. Dacco, M. Grassi, A. Citterio, R. Menotti et al., Effects of cigarette smoking on neuropsychological performance in mood disorders: a comparison between smoking and nonsmoking inpatients, J Clin Psychiatry, vol.74, issue.2, pp.130-136, 2013.

D. Morisano, V. C. Wing, K. A. Sacco, T. Arenovich, and T. P. George, Effects of Tobacco Smoking on Neuropsychological Function in Schizophrenia in Comparison to Other Psychiatric Disorders and Non-psychiatric Controls: Smoking Status and Cognition in Psychiatric Disorders, Am J Addict. janv, vol.22, issue.1, pp.46-53, 2013.

C. Law, J. K. Soczynska, H. O. Woldeyohannes, A. Miranda, J. O. Brooks et al., Relation between cigarette smoking and cognitive function in euthymic individuals with bipolar disorder, Pharmacol Biochem Behav. mars, vol.92, issue.1, pp.12-18, 2009.

J. M. Williams, K. K. Gandhi, and N. L. Benowitz, Carbamazepine but Not Valproate Induces CYP2A6 Activity in Smokers with Mental Illness, Cancer Epidemiol Biomarkers Prev, vol.19, issue.10, pp.2582-2591, 2010.

M. Burmeister, M. G. Mcinnis, and S. Zöllner, Psychiatric genetics: progress amid controversy, Nat Rev Genet. juill, vol.9, issue.7, pp.527-567, 2008.

C. Lerman and W. Berrettini, Elucidating the role of genetic factors in smoking behavior and nicotine dependence, Am J Med Genet. 1 avr, vol.118, issue.1, pp.48-54, 2003.

R. C. Mceachin, N. L. Saccone, S. F. Saccone, Y. D. Kleyman-smith, T. Kar et al., Modeling complex genetic and environmental influences on comorbid bipolar disorder with tobacco use disorder, Disponible sur, vol.11

G. Kenna, Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy. Pharmacogenomics Pers Med, janv, vol.19, 2012.

M. R. Pizzo-de-castro, V. Nunes, S. O. Guembarovski, R. L. Ariza, C. B. Oda et al., STin2 VNTR polymorphism is associated with comorbid tobacco use and mood disorders, J Affect Disord. févr, vol.172, pp.347-54, 2015.

S. David, M. Munafò, M. Murphy, R. Walton, and E. Johnstone, The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: Follow-up of a randomized controlled trial, Nicotine Tob Res, vol.9, issue.2, pp.225-256, 2007.

E. Zerdazi, J. Oliveira, F. Vorspan, M. Bennabi, S. Jamain et al., TLR4 gene polymorphism associated with lifetime cigarette smoking in bipolar disorder, J Neuroimmunol. avr, vol.305, pp.96-101, 2017.

P. Pruunsild, A. Kazantseva, T. Aid, K. Palm, and T. Timmusk, Dissecting the human BDNF locus: Bidirectional transcription, complex splicing, and multiple promoters, Genomics. sept, vol.90, issue.3, pp.397-406, 2007.

A. Slyepchenko, A. R. Brunoni, R. S. Mcintyre, J. Quevedo, and A. F. Carvalho, The Adverse Effects of Smoking on Health Outcomes in Bipolar Disorder: A Review and Synthesis of Biological Mechanisms, Curr Mol Med. 4 févr, vol.16, issue.2, pp.187-205, 2016.

F. S. Neves, L. Malloy-diniz, M. A. Romano-silva, S. B. Campos, D. M. Miranda et al., The role of BDNF genetic polymorphisms in bipolar disorder with psychiatric comorbidities, J Affect Disord. juin, vol.131, issue.1-3, pp.307-318, 2011.

S. H. Mitchell, Measuring Impulsivity and Modeling Its Association With Cigarette Smoking, Behav Cogn Neurosci Rev. déc, vol.3, issue.4, pp.261-75, 2004.

K. A. Perkins, C. Lerman, S. B. Coddington, C. Jetton, J. L. Karelitz et al., Initial nicotine sensitivity in humans as a function of impulsivity. Psychopharmacology (Berl), vol.200, pp.529-573, 2008.

A. C. Swann, J. C. Anderson, D. M. Dougherty, and F. G. Moeller, Measurement of inter-episode impulsivity in bipolar disorder, Psychiatry Res. mars, vol.101, issue.2, pp.195-202, 2001.

A. C. Swann, M. Lijffijt, S. D. Lane, J. L. Steinberg, and F. G. Moeller, Increased trait-like impulsivity and course of illness in bipolar disorder, Bipolar Disord. mai, vol.11, issue.3, pp.280-288, 2009.

S. M. Strakowski, D. E. Fleck, M. P. Delbello, C. M. Adler, P. K. Shear et al., Impulsivity across the course of bipolar disorder: Impulsivity in bipolar disorder, Bipolar Disord. mai, vol.12, issue.3, pp.285-97, 2010.

F. G. Moeller, E. S. Barratt, D. M. Dougherty, J. M. Schmitz, and A. C. Swann, Psychiatric Aspects of Impulsivity, Am J Psychiatry, vol.158, issue.11, pp.1783-93, 2001.

A. C. Swann, D. M. Dougherty, P. J. Pazzaglia, M. Pham, and F. G. Moeller, Impulsivity: a link between bipolar disorder and substance abuse, Bipolar Disord. juin, vol.6, issue.3, pp.204-216, 2004.

J. L. Heffner, D. E. Fleck, M. P. Delbello, C. M. Adler, and S. M. Strakowski, Cigarette smoking and impulsivity in bipolar disorder: Cigarette smoking and impulsivity, Bipolar Disord, vol.14, issue.7, pp.735-777, 2012.

A. M. Leventhal and M. Zimmerman, The relative roles of bipolar disorder and psychomotor agitation in substance dependence, Psychol Addict Behav, vol.24, issue.2, pp.360-365, 2010.

E. R. Walker, R. E. Mcgee, and B. G. Druss, Mortality in Mental Disorders and Global Disease Burden Implications: A Systematic Review and Meta-analysis, JAMA Psychiatry. 1 avr, vol.72, issue.4, p.334, 2015.

B. Roshanaei-moghaddam and W. Katon, Premature Mortality From General Medical Illnesses Among Persons With Bipolar Disorder: A Review, vol.60, p.10, 2009.

C. Crump, K. Sundquist, M. A. Winkleby, and J. Sundquist, Comorbidities and Mortality in Bipolar Disorder: A Swedish National Cohort Study, JAMA Psychiatry. 1 sept, vol.70, issue.9, p.931, 2013.

M. Weiner, L. Warren, and J. G. Fiedorowicz, Cardiovascular Morbidity and Mortality in Bipolar Disorder, vol.13, 2011.

C. P. Carney and L. E. Jones, Medical Comorbidity in Women and Men With Bipolar Disorders: A Population-Based Controlled Study, Psychosom Med. sept, vol.68, issue.5, pp.684-91, 2006.

J. G. Fiedorowicz, N. M. Palagummi, V. L. Forman-hoffman, D. D. Miller, and W. G. Haynes, Elevated Prevalence of Obesity, Metabolic Syndrome, and Cardiovascular Risk Factors in Bipolar Disorder

, Ann Clin Psychiatry. août, vol.20, issue.3, pp.131-138, 2008.

A. M. Kilbourne, J. R. Cornelius, X. Han, H. A. Pincus, M. Shad et al., Burden of general medical conditions among individuals with bipolar disorder, Bipolar Disord, vol.6, issue.5, pp.368-73, 2004.

B. I. Goldstein, A. Fagiolini, P. Houck, and D. J. Kupfer, Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States, Bipolar Disord. sept, vol.11, issue.6, pp.657-62, 2009.

F. A. Gomes, K. M. Almeida, P. V. Magalhães, S. C. Caetano, M. Kauer-sant'anna et al., Cardiovascular risk factors in outpatients with bipolar disorder: a report from the Brazilian Research Network in Bipolar Disorder, Rev Bras Psiquiatr. juin, vol.35, issue.2, pp.126-156, 2013.

M. Pérez-piñar, R. Mathur, Q. Foguet, S. Ayis, J. Robson et al., Cardiovascular risk factors among patients with schizophrenia, bipolar, depressive, anxiety, and personality disorders, Eur Psychiatry. mai, vol.35, pp.8-15, 2016.

B. Silarova, E. J. Giltay, A. Van-reedt-dortland, E. Van-rossum, E. Hoencamp et al., Metabolic syndrome in patients with bipolar disorder: Comparison with major depressive disorder and non-psychiatric controls, J Psychosom Res. avr, vol.78, issue.4, pp.391-399, 2015.

A. Kumar, J. C. Narayanaswamy, G. Venkatasubramanian, R. Raguram, S. Grover et al., Prevalence of metabolic syndrome and its clinical correlates among patients with bipolar disorder, Asian J Psychiatry. avr, vol.26, pp.109-123, 2017.

S. Grover, A. Mehra, R. Chakravarty, G. Jagota, and S. Sahoo, Change in prevalence of metabolic syndrome in patients with bipolar disorder, Asian J Psychiatry. janv, vol.47, p.101876, 2020.

A. Fagiolini, E. Frank, J. A. Scott, S. Turkin, and D. J. Kupfer, Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians, Bipolar Disord, vol.7, issue.5, pp.424-454, 2005.

M. Barchana, I. Levav, I. Lipshitz, I. Pugachova, R. Kohn et al., Enhanced cancer risk among patients with bipolar disorder, J Affect Disord. mai, vol.108, issue.1-2, pp.43-51, 2008.

G. Lin, Y. Chen, D. Kuo, L. Jaiteh, Y. Wu et al., Cancer Incidence in Patients With Schizophrenia or Bipolar Disorder: A Nationwide Population-Based Study in Taiwan, Schizophr Bull. 1 mars, vol.39, issue.2, pp.407-423, 1997.

N. R. Kahan, B. Silverman, I. Liphshitz, D. Waitman, I. Ben-zion et al., No apparent association between bipolar disorder and cancer in a large epidemiological study of outpatients in a managed care population, Int Clin Psychopharmacol. mars, vol.33, issue.2, pp.73-81, 2018.

N. Zareifopoulos, A. Bellou, A. Spiropoulou, and K. Spiropoulos, Prevalence of Comorbid Chronic Obstructive Pulmonary Disease in Individuals Suffering from Schizophrenia and Bipolar Disorder: A Systematic Review, COPD J Chronic Obstr Pulm Dis, vol.15, issue.6, pp.612-632, 2018.

R. S. Mcintyre, J. Z. Konarski, J. K. Soczynska, K. Wilkins, G. Panjwani et al., Medical Comorbidity in Bipolar Disorder: Implications for Functional Outcomes and Health Service Utilization, Psychiatr Serv, vol.57, issue.8, p.5, 2006.

R. C. Callaghan, S. Veldhuizen, T. Jeysingh, C. Orlan, C. Graham et al., Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression, J Psychiatr Res. janv, vol.48, issue.1, pp.102-112, 2014.

S. Dodd, A. Brnabic, L. Berk, P. B. Fitzgerald, A. R. De-castella et al., A prospective study of the impact of smoking on outcomes in bipolar and schizoaffective disorder. Compr Psychiatry, vol.51, pp.504-513, 2010.

L. Gutirrez-rojas, M. Gurpegui, J. L. Ayuso-mateos, J. A. Gutirrez-ariza, M. Ruiz-veguilla et al., Quality of life in bipolar disorder patients: a comparison with a general population sample, Bipolar Disord. août, vol.10, issue.5, pp.625-659, 2008.

C. W. Colton and R. W. Manderscheid, Congruencies in Increased Mortality Rates, Years of Potential Life Lost, and Causes of Death Among Public Mental Health Clients in Eight States, vol.3, p.14, 2006.

I. Berlin and L. S. Covey, Pre-cessation depressive mood predicts failure to quit smoking: the role of coping and personality traits, Addiction. déc, vol.101, issue.12, pp.1814-1835, 2006.

L. Stepankova, E. Kralikova, K. Zvolska, A. Pankova, P. Ovesna et al., Depression and Smoking Cessation: Evidence from a Smoking Cessation Clinic with 1-Year Follow-Up. Ann Behav Med, vol.51, pp.454-63, 2017.

J. L. Heffner, M. P. Delbello, D. E. Fleck, R. M. Anthenelli, and S. M. Strakowski, Cigarette smoking in the early course of bipolar disorder: association with ages-at-onset of alcohol and marijuana use, Bipolar Disord, vol.10, issue.7, pp.838-883, 2008.

E. S. Rogers, R. Friedes, A. Jakes, E. Grossman, A. Link et al., Long-term abstinence and predictors of tobacco treatment uptake among hospitalized smokers with serious mental illness enrolled in a smoking cessation trial, J Behav Med, vol.40, issue.5, pp.750-759, 2017.

F. Sarramea, M. J. Jaen-moreno, V. Balanzá-martínez, M. I. Osuna, J. Á. Alcalá et al., Preparando el escenario para dejar de fumar en el paciente con Trastorno Bipolar: intervención breve en la práctica clínica, Adicciones. 13 juill, vol.31, issue.2, p.136, 2018.

L. E. Travaglini, L. Li, C. H. Brown, and M. E. Bennett, Predictors of smoking cessation group treatment engagement among veterans with serious mental illness, Addict Behav. déc, vol.75, pp.103-110, 2017.

J. J. Prochaska, R. S. Reyes, S. A. Schroeder, A. S. Daniels, A. Doederlein et al., An online survey of tobacco use, intentions to quit, and cessation strategies among people living with bipolar disorder: Tobacco use and bipolar disorder, Bipolar Disord. août, vol.13, issue.5-6, pp.466-73, 2011.

A. J. Mitchell, D. Vancampfort, D. Hert, M. Stubbs, and B. , Do people with mental illness receive adequate smoking cessation advice? A systematic review and meta-analysis, Gen Hosp Psychiatry. janv, vol.37, issue.1, pp.14-23, 2015.

R. D. Pattanayak, R. Sagar, and R. Jain, Perceived health risks, attitude and readiness to quit tobacco among euthymic bipolar disorder patients in regular contact with mental health services: An exploratory study from India, J Ment Health. févr, vol.21, issue.1, pp.83-90, 2012.

J. L. Heffner, N. L. Watson, J. B. Mcclure, R. M. Anthenelli, S. Hohl et al., I Smoke Like This to Suppress These Issues That Are Flaws of My Character": Challenges and Facilitators of Cessation Among Smokers With Bipolar Disorder, J Dual Diagn. 2 janv, vol.14, issue.1, pp.32-41, 2018.

M. P. Garcia-portilla, L. Garcia-alvarez, F. Sarramea, G. Galvan, E. Diaz-mesa et al., It is feasible and effective to help patients with severe mental disorders to quit smoking: An ecological pragmatic clinical trial with transdermal nicotine patches and varenicline. Schizophr Res, vol.176, pp.272-80, 2016.

L. Banham and S. Gilbody, Smoking cessation in severe mental illness: what works?: Smoking cessation in severe mental illness, Addiction. 11 mai, vol.105, issue.7, pp.1176-89, 2010.

I. Pacchiarotti, D. J. Bond, R. J. Baldessarini, W. A. Nolen, H. Grunze et al., The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders, Am J Psychiatry, vol.170, issue.11, pp.1249-62, 2013.

J. L. Heffner, A. E. Evins, C. Russ, D. Lawrence, C. R. Ayers et al., Safety and efficacy of firstline smoking cessation pharmacotherapies in bipolar disorders: Subgroup analysis of a randomized clinical trial, J Affect Disord. sept, vol.256, pp.267-77, 2019.

G. Taylor, T. Itani, K. H. Thomas, D. Rai, T. Jones et al., Prescribing Prevalence, Effectiveness, and Mental Health Safety of Smoking Cessation Medicines in Patients With Mental Disorders, Nicotine Tob Res, vol.10, issue.2019

D. Sur,

D. Kotz, W. Viechtbauer, C. Simpson, O. Van-schayck, R. West et al., Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study, Lancet Respir Med, vol.3, issue.10, pp.761-769, 2015.

Q. Wu, S. Gilbody, E. Peckham, S. Brabyn, and S. Parrott, Varenicline for smoking cessation and reduction in people with severe mental illnesses: systematic review and meta-analysis: Varenicline for smoking cessation in SMI, Addiction. sept, vol.111, issue.9, pp.1554-67, 2016.

K. Chengappa, K. A. Perkins, J. S. Brar, P. J. Schlicht, S. R. Turkin et al., Varenicline for Smoking Cessation in Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Study, J Clin Psychiatry. 15 juill, vol.75, issue.07, pp.765-72, 2014.

A. E. Evins, C. Cather, S. A. Pratt, G. N. Pachas, S. S. Hoeppner et al., Maintenance Treatment With Varenicline for Smoking Cessation in Patients With Schizophrenia and Bipolar Disorder: A Randomized Clinical Trial, JAMA. 8 janv, vol.311, issue.2, p.145, 2014.

R. M. Schuster, C. Cather, G. N. Pachas, H. Zhang, K. M. Cieslak et al., Predictors of tobacco abstinence in outpatient smokers with schizophrenia or bipolar disorder treated with varenicline and cognitive behavioral smoking cessation therapy, Addict Behav. août, vol.71, pp.89-95, 2017.

A. Ahmed, A manic episode in a 64-year-old man: an adverse effect of varenicline, Gen Hosp Psychiatry. mars, vol.33, issue.2, 2011.

F. Alhatem and J. E. Black, Varenicline-Induced Mania in a Bipolar Patient, Clin Neuropharmacol. mars, vol.32, issue.2, pp.117-125, 2009.

M. Cantrell, T. Argo, L. Haak, and L. Janney, Adverse Neuropsychiatric Events Associated with Varenicline Use in Veterans: A Case Series, Issues Ment Health Nurs, vol.33, issue.10, pp.665-674, 2012.

D. Francois, A. Odom, and N. Kotbi, A case of late-life onset mania during Varenicline assisted smoking cessation, Int J Geriatr Psychiatry. juin, vol.26, issue.6, pp.658-667, 2011.

S. Hussain, E. Kayne, N. Guwanardane, and G. Petrides, Varenicline induced mania in a 51 year old patient without history of bipolar illness, Prog Neuropsychopharmacol Biol Psychiatry. juin, vol.35, issue.4, pp.1162-1165, 2011.

N. Knibbs and D. T. Tsoi, Varenicline induces manic relapse in bipolar disorder, Gen Hosp Psychiatry, vol.33, issue.6, pp.641-642, 2011.

C. Chu, C. Kao, and C. Chan, Could the nicotine receptor partial agonist varenicline moderate manic symptoms in heavy smokers with manic episodes?, Aust N Z J Psychiatry. févr, vol.52, issue.2, pp.205-205, 2018.

J. L. Heffner, R. M. Anthenelli, M. P. Delbello, L. Stahl, and S. M. Strakowski, Mood Management and Nicotine Patch for Smoking Cessation in Adults With Bipolar Disorder, Nicotine Tob Res, vol.15, issue.11, pp.1805-1811, 2013.

J. L. Heffner, J. B. Mcclure, K. E. Mull, R. M. Anthenelli, and J. B. Bricker, Acceptance and Commitment Therapy and nicotine patch for smokers with bipolar disorder: preliminary evaluation of inperson and telephone-delivered treatment, Bipolar Disord. août, vol.17, issue.5, pp.560-566, 2015.

S. Mccrabb, A. L. Baker, J. Attia, E. Skelton, L. Twyman et al., Internet-Based Programs Incorporating Behavior Change Techniques Are Associated With Increased Smoking Cessation in the General Population: A Systematic Review and Meta-analysis, Ann Behav Med. 1 févr, vol.53, issue.2, pp.180-95, 2019.

J. L. Heffner, M. M. Kelly, J. Waxmonsky, K. Mattocks, E. Serfozo et al., Pilot Randomized Controlled Trial of Web-Delivered Acceptance and Commitment Therapy Versus Smokefree.gov for Smokers With Bipolar Disorder, Nicotine Tob Res

D. Sur,

S. Gilbody, E. Peckham, D. Bailey, C. Arundel, P. Heron et al., Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trial, Lancet Psychiatry. mai, vol.6, issue.5, pp.379-90, 2019.

J. J. Prochaska, S. E. Hall, K. Delucchi, and S. M. Hall, Efficacy of Initiating Tobacco Dependence Treatment in Inpatient Psychiatry: A Randomized Controlled Trial, Am J Public Health. août, vol.104, issue.8, pp.1557-65, 2014.

M. F. Brunette, S. I. Pratt, S. J. Bartels, E. A. Scherer, S. C. Sigmon et al., Randomized Trial of Interventions for Smoking Cessation Among Medicaid Beneficiaries With Mental Illness, Psychiatr Serv. mars, vol.69, issue.3, pp.274-80, 2018.

S. Boumaza, P. Lebain, and P. Brazo, Interdiction stricte du tabac : impact sur le risque de violence dans une unité de soins intensifs psychiatrique, L'Encéphale. juin, vol.41, pp.1-6, 2015.

D. Robson, G. Spaducci, A. Mcneill, D. Stewart, T. Craig et al., Effect of implementation of a smoke-free policy on physical violence in a psychiatric inpatient setting: an interrupted time series analysis, Lancet Psychiatry. juill, vol.4, issue.7, pp.540-546, 2017.

V. Hollen, G. Ortiz, L. Schacht, M. G. Mojarrad, G. Jr et al., Effects of Adopting a Smoke-Free Policy in State Psychiatric Hospitals, vol.61, p.6, 2010.

C. Okoli, Y. D. Al-mrayat, C. I. Shelton, and M. Khara, A retrospective analysis of the association between providing nicotine replacement therapy at admission and motivation to quit and nicotine withdrawal symptoms during an inpatient psychiatric hospitalization, Addict Behav. oct, vol.85, pp.131-139, 2018.

S. Zhu, S. E. Cummins, A. C. Gamst, S. Wong, and T. Ikeda, Quitting smoking before and after varenicline: a population study based on two representative samples of US smokers, Tob Control. juill, vol.25, issue.4, pp.464-473, 2016.

R. Icick, S. Gard, M. Barde, M. Carminati, A. Desage et al., Physical and mental health burden in cases of bipolar disorder classified as current, former, or non-tobacco smokers, J Affect Disord. janv, vol.208, pp.406-419, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01806738

J. Ehrbar, S. Brand, F. Colledge, L. Donath, S. T. Egger et al., Psychiatric In-Patients Are More Likely to Meet Recommended Levels of Health-Enhancing Physical Activity If They Engage in Exercise and Sport Therapy Programs. Front Psychiatry, vol.20, 2018.

A. H. Taylor, T. P. Thompson, C. J. Greaves, R. S. Taylor, C. Green et al., A pilot randomised trial to assess the methods and procedures for evaluating the clinical effectiveness and cost-effectiveness of Exercise Assisted Reduction then Stop (EARS) among disadvantaged smokers. Health Technol Assess, vol.18, 2014.